FiercePharma

Competition for Early-Line Biologic Use among Psoriasis Patients Intensifies as Humira Continues to Gain Ground on Enbrel

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that competition for early-line use of Amgen/Pfizer's Enbrel and ...
Reuters

UK favours Humira, Enbrel for psoriatic arthritis

LONDON, March 15 (Reuters) - Abbott Laboratories' drug Humira and Enbrel, from Pfizer and Amgen , should be the first choices for treating patients with psoriatic arthritis, Britain's ...
Crain's Chicago Business

Humira, AbbVie in the spotlight in Outcome Health trial

AbbVie and its longtime blockbuster arthritis drug Humira are now front and center in the Outcome Health trial. Outcome Health was a high-flying Chicago company that made headlines when it raised $488 ...
Business Insider

Global $24.2 Bn Plaque Psoriasis Drug Forecast and Market to 2027: Amgen's Enbrel, Janssen's Remicade and AbbVie's Humira Dominated the Market for Over 10 Years

Dublin, June 21, 2019 (GLOBE NEWSWIRE) -- The "Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2027" report has been added to ResearchAndMarkets.com's offering. "Plaque Psoriasis: Global ...